A new daily tablet for type 2 diabetes and weight management has launched in UK pharmacies, giving eligible patients another option beyond injectable treatments.

The medicine, orforglipron, is being made available in the UK from Monday, 24 August, according to reports. The daily pill is designed to help control blood sugar in people with type 2 diabetes and can also support weight loss.

The arrival of a tablet-based treatment could attract significant interest among people who have been reluctant to use injectable weight-loss medicines. It also comes as demand for GLP-1-based treatments and medical weight management continues to grow.

Healthcare professionals stress that weight-loss medicines are not suitable for everyone and should be used under appropriate medical supervision. Lifestyle measures, including diet and physical activity, remain important parts of managing weight and type 2 diabetes.

The UK launch comes amid rapid development in the obesity-treatment market, where pharmaceutical companies are competing to provide increasingly convenient alternatives to injections.

The availability of a daily tablet could mark an important shift in how some patients approach medical weight management in Britain.